Replies to post #143023 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

That's probably why they have Jordana S. Rubel as their "attorney of record" working on their trademark.

Jordana S. Rubel advises clients on a variety of intellectual property (IP) matters, including litigation, unfair competition, licensing, and patent, trademark, and copyright prosecution and enforcement. With many companies now holding international trademark portfolios, Jordana also counsels clients on developing international IP strategies that protect their brands worldwide. She regularly advises companies on international trademark portfolio management, including initiating and defending trademark opposition and cancellation actions and litigation.
https://www.morganlewis.com/bios/jrubel

Still, I think LP and LG are more than familiar with the trademark and patent processes as they've been at it some time.

https://www.nwbio.com/northwest-bio-reaffirms-its-freedom-to-operate-refutes-other-parties-misleading-patent-assertions-2/

And according to Linda's biography, protecting one's intellectual property figures quite strongly in it.

Ms. Linda F. Powers, J.D., has been the Chief Executive Officer and President of Northwest Biotherapeutics, Inc. since June 8, 2011 and also serves as its Chief Financial Officer and Accounting Officer. Ms. Powers serves as Managing Director of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She is a Co-Founder of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She has more than 25 years of experience in the fields of venture capital, public-private partnerships, corporate finance and restructurings, mergers and acquisitions, joint ventures, IP licensing and highly leveraged, structured and specialty finance transactions and more than six years of experience in seed and early stage venture capital investing. Prior to Toucan Capital, she served as Senior Vice President of Global Finance at Enron Corp. Prior to joining Enron, she served as a Deputy Assistant Secretary of Commerce in the Bush Administration from 1989 to 1993. In that capacity, she was responsible for a number of small business programs, mainly concerned with access to capital. She also assisted financial services, information services and related businesses in entering foreign markets and was responsible for government to government negotiations to remove foreign market entry restrictions for U.S. firms. In addition, Ms. Powers served as a co-lead negotiator for United States on the North American Free Trade Agreement and financial sector agreement, which opened banking, securities, insurance, pension fund and related opportunities in Canada and Mexico. During 1980’s, she practiced law, specializing in corporate mergers, acquisitions and financings and certain kinds of intellectual property transactions. While working for the headquarters of the European Union in Brussels, she was responsible for drafting the initial intellectual property rules, which now govern know how licensing in the European Union. Ms. Powers has been the Chairperson and Director of Northwest Biotherapeutics, Inc. since May 17, 2007. She has been a Director of Q Holdings, Inc. (formerly Grace 2, Inc.) since October 13, 2011. She serves as a Director of Pepgen Corporation and Moffitt Genetics Corporation, Inc. Ms. Powers served as Director of Q Therapeutics, Inc. from April 2004 to December 11, 2015. She served as a Director of Reactive NanoTechnologies, Inc. She serves as a Trustee of Trudeau Institute, Inc. She serves on the Steering Committee at the National Academy of Sciences, evaluating Federal grant programs and on the Advisory Board at the U.S. Department of Commerce NIST Advanced Technology Program. She has served for several years on the Technology Advisory Board of the Moffitt Cancer Center in Tampa. Ms. Powers also served on the Investment Board of Maryland's state-run seed and early stage venture capital fund. Over seven years, she has become a recognized leader in the stem cell industry nationwide in the United States, as well as in Europe, India and China and has served as the Chair of Maryland's Stem Cell Commission, where she was responsible for administering the state's stem cell research funding for the first two years of the program. She has been appointed to key technology and industry commissions by the Governors of two states. Her board service includes various public boards including the Virginia Research and Technology Advisory Committee, the Advisory Board of the U.S. National Institutes of Standards and Technology's Advanced Technology Program. Ms. Powers served on the Maryland Governor's Commission on the Development of Advanced Technology Businesses and Maryland's Enterprise Investment Fund. She co-teaches a course on Entrepreneurship for Scientists at the National Institute of Health for six years and has taught International Business Transactions and European Business Law as an Adjunct Professor at Georgetown Law School for eight years. Ms. Powers received a J.D. degree, magna cum laude, from Harvard Law School. She holds a B.A. in Economics from Woodrow Wilson School, Princeton University, where Ms. Powers graduated magna cum laude and Phi Beta Kappa.